CN117305388B - Application of bacillus bailii SL-K2 in preparation of guanine extract, preparation method of guanine extract and application - Google Patents
Application of bacillus bailii SL-K2 in preparation of guanine extract, preparation method of guanine extract and application Download PDFInfo
- Publication number
- CN117305388B CN117305388B CN202311245655.0A CN202311245655A CN117305388B CN 117305388 B CN117305388 B CN 117305388B CN 202311245655 A CN202311245655 A CN 202311245655A CN 117305388 B CN117305388 B CN 117305388B
- Authority
- CN
- China
- Prior art keywords
- guanine
- extract
- bacillus
- preparation
- dry powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 title claims abstract description 136
- 239000000284 extract Substances 0.000 title claims abstract description 73
- 241000193830 Bacillus <bacterium> Species 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 238000000855 fermentation Methods 0.000 claims abstract description 32
- 230000004151 fermentation Effects 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 25
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims abstract description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 241000223218 Fusarium Species 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000011282 treatment Methods 0.000 claims abstract description 20
- 230000008635 plant growth Effects 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 9
- 239000002244 precipitate Substances 0.000 claims abstract description 7
- 239000006228 supernatant Substances 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 6
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 6
- 238000000502 dialysis Methods 0.000 claims abstract description 4
- 238000000227 grinding Methods 0.000 claims abstract description 4
- 229920002521 macromolecule Polymers 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 230000001376 precipitating effect Effects 0.000 claims abstract description 3
- 238000001556 precipitation Methods 0.000 claims abstract description 3
- 238000004321 preservation Methods 0.000 claims abstract description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 30
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241000221779 Fusarium sambucinum Species 0.000 claims description 13
- 239000001963 growth medium Substances 0.000 claims description 12
- 239000000725 suspension Substances 0.000 claims description 12
- 238000009630 liquid culture Methods 0.000 claims description 9
- 241000223221 Fusarium oxysporum Species 0.000 claims description 8
- 208000035240 Disease Resistance Diseases 0.000 claims description 7
- 241001481296 Malus spectabilis Species 0.000 claims description 7
- 241001052560 Thallis Species 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 230000000415 inactivating effect Effects 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 235000005822 corn Nutrition 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000001888 Peptone Substances 0.000 claims description 4
- 108010080698 Peptones Proteins 0.000 claims description 4
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 235000015278 beef Nutrition 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 235000019319 peptone Nutrition 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 3
- 241000218993 Begonia Species 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 230000001580 bacterial effect Effects 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000011097 chromatography purification Methods 0.000 abstract description 2
- 210000004215 spore Anatomy 0.000 description 23
- 241000196324 Embryophyta Species 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 18
- 150000002500 ions Chemical class 0.000 description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 235000012015 potatoes Nutrition 0.000 description 10
- 230000003042 antagnostic effect Effects 0.000 description 9
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 244000052616 bacterial pathogen Species 0.000 description 8
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 229940118019 malondialdehyde Drugs 0.000 description 8
- 230000035882 stress Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 238000001819 mass spectrum Methods 0.000 description 7
- 230000000813 microbial effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- HVMRLFSFHWCUCG-UHFFFAOYSA-N 2,6-diamino-5-nitroso-1h-pyrimidin-4-one Chemical compound NC1=NC(=O)C(N=O)=C(N)N1 HVMRLFSFHWCUCG-UHFFFAOYSA-N 0.000 description 5
- 229930002868 chlorophyll a Natural products 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- 239000000411 inducer Substances 0.000 description 4
- 238000011419 induction treatment Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- 239000005712 elicitor Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- ANGDWNBGPBMQHW-UHFFFAOYSA-N methyl cyanoacetate Chemical compound COC(=O)CC#N ANGDWNBGPBMQHW-UHFFFAOYSA-N 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000004382 potting Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WXHAZYIZRSJMKP-UHFFFAOYSA-N C(=O)O.N1C(N)=NC=2N=CNC2C1=O Chemical compound C(=O)O.N1C(N)=NC=2N=CNC2C1=O WXHAZYIZRSJMKP-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241001033764 Fusarium foetens Species 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 241001148470 aerobic bacillus Species 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000007034 nitrosation reaction Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940075420 xanthine Drugs 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- SWELIMKTDYHAOY-UHFFFAOYSA-N 2,4-diamino-6-hydroxypyrimidine Chemical compound NC1=CC(=O)N=C(N)N1 SWELIMKTDYHAOY-UHFFFAOYSA-N 0.000 description 1
- SYEYEGBZVSWYPK-UHFFFAOYSA-N 2,5,6-triamino-4-hydroxypyrimidine Chemical compound NC1=NC(N)=C(N)C(O)=N1 SYEYEGBZVSWYPK-UHFFFAOYSA-N 0.000 description 1
- IBAOFQIOOBQLHE-UHFFFAOYSA-N 2-amino-3,9-dihydropurin-9-ium-6-one;chloride Chemical compound Cl.N1C(N)=NC(=O)C2=C1N=CN2 IBAOFQIOOBQLHE-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000005087 Malus prunifolia Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000010094 cellular senescence Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000011363 dried mixture Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- NDEMNVPZDAFUKN-UHFFFAOYSA-N guanidine;nitric acid Chemical compound NC(N)=N.O[N+]([O-])=O.O[N+]([O-])=O NDEMNVPZDAFUKN-UHFFFAOYSA-N 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical class [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- RSKNEEODWFLVFF-UHFFFAOYSA-N sulfuric acid;2,5,6-triamino-1h-pyrimidin-4-one Chemical compound OS(O)(=O)=O.NC1=NC(=O)C(N)=C(N)N1 RSKNEEODWFLVFF-UHFFFAOYSA-N 0.000 description 1
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 description 1
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P21/00—Plant growth regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pest Control & Pesticides (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Agronomy & Crop Science (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dentistry (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses an application of bacillus beleiensis SL-K2 in preparation of guanine extract, a preparation method of the guanine extract and an application thereof, wherein the bacillus beleiensis can be used for preparing the guanine extract and has a preservation number of CGMCC 28155. The preparation method of guanine extract comprises: s1, centrifuging fermentation liquor of bacillus belicus SL-K2, and reserving a fermentation liquor supernatant; s2, drying and grinding the supernatant of the fermentation broth into dry powder; s3, carrying out alcohol precipitation on the dry powder by 8-12 times of ethanol, keeping for 20-30 hours, and filtering and precipitating to obtain a primary extract; s4, removing ethanol in the precipitate, preparing dry powder, dissolving the dry powder, performing dialysis treatment, and removing macromolecules above 500Da to obtain a secondary extract; s5, performing HPLC chromatographic purification on the secondary extract, and separating to obtain guanine extract. The guanine extract is used as bacterial fermentation broth extract, has good Fusarium resistance and plant growth promotion effects, and has the advantages of extremely low cost, strong process adaptability, green and safe.
Description
Technical Field
The invention relates to the technical field of microbial extracts, in particular to application of bacillus beijerinus SL-K2 in preparation of guanine extracts, and a preparation method and application of the guanine extracts.
Background
Potatoes are annual herbs of the genus solanum of the family solanaceae, which are a non-cereal food crop for human consumption, the first one in the potato rank is the fourth largest crop next to rice, corn and wheat, playing a significant role in food safety in developing countries. The mountain land of the tropical america of the original potato is transferred to india in the 16 th century and then to china, and is now widely planted in the temperate region of the world. About 13 million people in china and india use fresh potatoes as staple food.
However, in potato planting, fungal diseases have been an important cause of the influence on the yield. Among the various soil-borne diseases, fusarium is the most common pathogen responsible for yield and commercial losses in potato production. At present, the control method of Fusarium potato diseases is mainly focused on chemical bactericides, rotation and breeding of resistant varieties. However, fusarium diseases are difficult to control due to rapid differentiation of pathogenicity of pathogenic bacteria, increase of drug-resistant pathogenic bacteria, and lack of high-resistance fine varieties.
At present, the main pathogenic bacteria causing fusarium diseases of potatoes in Shandong and other areas are fusarium wilt of crabapple (the scholaris name: fusarium foetens), the report of the novel pathogenic bacteria is published in 4 months of 2023, and the widely distributed pathogenic bacteria at present, namely article name :"Mechanisms of Surfactin from Bacillus subtilis SF1 against Fusarium foetens:A Novel Pathogen Inducing Potato Wilt". in Journal of Fungi, cause serious yield reduction on potato planting, are objects needing to be mainly controlled, but the green and safe bacterial antagonist on the market at present has poor control effect on the pathogenic bacteria.
If the stress resistance of the potatoes to diseases is fundamentally improved, the yield of the potatoes can be greatly improved, the dosage of various bactericides in fields is reduced, and the method is more scientific and environment-friendly. However, no effective agent for improving fusarium diseases of potatoes exists at present.
Accordingly, there is a need for further improvements in the art.
Disclosure of Invention
In order to solve the problems, the invention provides the application of bacillus belicus SL-K2 in preparing the guanine extract, the preparation method and the application of the guanine extract, and the guanine extract is successfully extracted from bacillus belicus SL-K2 for the first time, has the effects of promoting plant growth and improving plant disease resistance, and can be used as an active ingredient of a medicament to play a role in potato planting industry.
In order to solve the problems, the application provides the following technical scheme:
In a first aspect, the application provides an application of bacillus beleiensis in preparing guanine extracts, wherein bacillus beleiensis SL-K2 is adopted, and the preservation number of the bacillus beleiensis is CGMCC 28155.
The bacillus beleiensis is separated and purified from sludge at the offshore river mouth of the urban wetland park in the sea city by the applicant, is named as bacillus beleiensis SL-K2 strain, and is preserved in China general microbiological culture collection center (CGMCC 28155) at the 8 th month 11 of 2023. The strain is facultative aerobic bacteria, gram positive bacteria, and spores are positioned in the middle or at the partial ends of the bacteria, so that the bacteria do not expand when the spores are generated, and the bacteria are in a rod shape. The strain is identified as a novel bacillus belay strain by sequencing and analyzing a 16S rDNA gene of the strain (Bacillus velezensis).
The inventor discovers that guanine extract can be extracted from the bacillus beijerinus SL-K2 strain for the first time, and the bacillus beijerinus has great application potential.
In a second aspect, the present application also provides a process for the preparation of guanine extracts, which process is: guanine extracts were extracted from fermentation broth of Bacillus bailii SL-K2.
Preferably, specifically, the preparation method of the guanine extract comprises the following steps:
s1, centrifuging fermentation liquor of bacillus belicus SL-K2, removing thalli, and reserving a fermentation liquor supernatant;
s2, drying and grinding the supernatant of the fermentation broth into powder to obtain dry powder of a fermentation broth mixture;
S3, carrying out alcohol precipitation on the dry powder by 10 times of volume of ethanol, keeping the temperature at 4 ℃ for 24 hours, filtering with filter paper, separating filtrate and precipitate, and precipitating to obtain a primary extract;
S4, removing ethanol in the precipitate obtained in the previous step, preparing dry powder, dissolving the dry powder in DMSO (dimethyl sulfoxide), performing dialysis treatment, and removing macromolecules above 500Da to obtain a secondary extract;
S5, performing HPLC (high Performance liquid chromatography) purification on the secondary extract, and separating to obtain 1 refined extract, wherein the refined extract is guanine extract.
Preferably, in the preparation method of the guanine extract, the preparation method of the fermentation broth of bacillus belgium SL-K2 in the step S1 comprises the following steps:
s0, inoculating bacillus belicus SL-K2 into a liquid culture medium, and shake culturing for 40-55 h, wherein the rotation speed of a shaking table is 120-200 rpm/min to obtain a culture solution; the liquid culture medium is added with fusarium microspore inactivating liquid of the malus spectabilis.
Preferably, the liquid culture medium comprises the following components in percentage by mass:
1 to 10 percent of fusarium microspore inactivating liquid with the concentration of 10 3~105/ml, 0.05 to 0.5 percent of beef extract, 0.1 to 1 percent of peptone and 0.1 to 1 percent of bean cake powder; corn steep liquor with the concentration of 0.5-3%; 0.05 to 0.3 percent of CaCO 3; 0.01-0.05% of MgSO 4 and the balance of water.
Preferably, the concentration of the fusarium oxysporum virens inactivating liquid is 10 4/ml.
Further preferably, the liquid culture medium comprises the following components in percentage by mass: the liquid culture medium comprises the following components in percentage by mass: 5% of 10 4/ml fusarium oxysporum liquid, 0.1% of beef extract, 0.5% of peptone and 0.5% of bean cake powder; corn steep liquor 1.0%; caCO 30.1%;MgSO4 0.03% and water as the rest.
Preferably, the preparation method of the fusarium oxysporum f.sp.begoniae inactivating liquid comprises the following steps: the microspore suspension of Fusarium roseum is treated at 55-65 deg.c for 20-40 min to maintain the integrity of spore cell morphology and lose germination activity, so as to obtain deactivated spore liquid.
Preferably, in the step S5, the chromatographic column is a Hypersil GOLD C18 column, the column temperature is 23-28 ℃, and the secondary extracting solution is carried out in a two-dimensional nano liquid phase system at the flow rate of 1.0ml/min at the flow rate of 0:3,1:9, 14:90, 13:7 and 18:5; eluent A adopts acetic acid (90%), B is an apodization system of acetonitrile and methanol (acetonitrile 8%, methanol 2%), and the chromatographic retention time is 1.5-1.6min.
In a third aspect, the present application also provides a guanine extract, which is prepared by the aforementioned preparation method.
Guanine is a major base constituent of nucleic acids and has important physiological functions. Meanwhile, guanine also has a plurality of medicinal values, is a medical intermediate of traditional Chinese medicines, such as a compound antiviral drug of acyclovir, ganciclovir and other zolo Wei Jilie drugs, and has great industrial production value.
However, at present, guanine is chemically synthesized by adopting a traditional production process and taking methyl cyanoacetate as a starting material, and mainly undergoes the following five chemical reactions in sequence:
(1) Condensation reaction: cyclizing methyl cyanoacetate with guanidine nitrate (or guanidine hydrochloride) to obtain 2, 4-diamino-6-hydroxypyrimidine; (2) nitrosation reaction: nitrosation reaction is carried out with sodium nitrite to obtain 2, 4-diamino-5-nitroso-6-hydroxypyrimidine. (3) hydrogenation reduction reaction: the 2,4, 5-triamino-6-hydroxy pyrimidine is obtained through hydrogenation or iron powder reduction. (4) salt formation reaction: reacting with sulfuric acid to obtain 2,4, 5-triamino-6-hydroxy pyrimidine sulfate. (5) cyclization reaction: reflux with sodium formate or formamide in formic acid to give guanine formate. And (3) decoloring and refining the guanine formate obtained by the cyclization reaction in dilute hydrochloric acid to obtain guanine hydrochloride, and then, performing free reaction in dilute alkaline water to obtain a guanine finished product.
In the traditional method, the third-step iron powder reduction reaction is forbidden, and the hydrogenation reduction has higher safety threshold due to the hydrogen and pressure, and in addition, the byproduct treatment difficulty is higher and the environmental protection treatment cost is high due to the use of liquid alkali, sulfuric acid and formic acid.
The guanine extract obtained by the preparation method provided by the invention is used as a bacterial fermentation broth extract, has good fusarium resistance and plant growth promotion effects, is extremely low in cost, strong in process suitability and high in safety, and more importantly, can be used as a plant immune elicitor to activate plant immune response, so that the disease resistance of crops is improved; the compound can become a novel medicament with green, safe and environment-friendly property, and has wide application prospect.
In a fourth aspect, the present application also provides a microbial immunity inducer, the active ingredient of which comprises the guanine extract. Experiments show that guanine has no bacteriostasis on fusarium in vitro, but can induce the disease resistance of plants and promote plant growth after acting on the plants.
In a fifth aspect, the application also provides the application of the guanine extract and the microbial immunity inducer in promoting plant growth.
In a sixth aspect, the application also provides an application of the guanine extract and the microbial immunity inducer in improving disease resistance of plants to Fusarium head blight. In the examples of the present application, the plants are exemplified by potatoes.
Experiments prove that the guanine extract prepared by the method provided by the application has obvious seedling strengthening and stress resisting effects on potatoes, promotes the growth of the potato seedlings, improves the disease resistance of the potato seedlings, and reduces the probability of infection of potato plants by fusarium, so that the guanine extract can be used as an active ingredient of a microbial immunity inducer and applied to the aspects of plant growth promotion and stress resistance improvement.
The invention has the following beneficial effects:
1. the application discovers a method for separating guanine extract from bacillus bailii SL-K2 which is automatically screened, and the guanine extract is used as a bacterial fermentation broth extract, has the effects of resisting fusarium and promoting plant growth, and has the advantages of extremely low cost, strong process suitability, high safety and no pollution to the environment, and more importantly, the guanine extract can be used as a plant immunity elicitor to activate plant immunity reaction so as to improve the disease resistance of crops, and can be applied to preparing microbial pesticides or related preparations.
2. The guanine extract has good application prospect, fully develops the application value of bacillus bailii and improves the utilization rate of bacillus bailii.
3. Compared with the traditional mode of producing guanine by using methyl cyanoacetate as a starting material through a chemical synthesis process, the microbial fermentation production method provided by the application is more environment-friendly, and solves the problems of higher byproduct treatment difficulty, high environmental protection treatment cost, higher safety threshold and the like in the traditional chemical synthesis method.
Drawings
FIG. 1 shows the results of bacteriostasis of Bacillus belicus SL-K2 on Fusarium roseum wilt of Malus;
FIG. 2 is an electron microscope image of vegetative cell and spore morphology of Bacillus bailii SL-K2; a is a vegetative cell, B is a spore;
FIG. 3 is a chemical structure diagram of guanine and xanthine;
FIG. 4 is a chromatogram of the negative ion of guanine extract;
FIG. 5 is a mass spectrum of negative ions of guanine extract;
FIG. 6 is a positive ion chromatogram of guanine extract;
FIG. 7 is a positive ion mass spectrum of guanine extract;
FIG. 8 is a comparison of the above-ground growth of potato seedlings treated in each experimental group of example 3;
FIG. 9 is the total weight of potato seedlings treated in each experimental group in example 3;
FIG. 10 is a comparison of chlorophyll a content of potatoes treated in each experimental group of example 3;
FIG. 11 is a comparison of soluble sugar content of potato leaf treated in each experimental group of example 3;
FIG. 12 is the malondialdehyde content of leaves treated in each experimental group in example 3.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to fall within the scope of the invention. In the present invention, the equipment, materials, etc. used are commercially available or commonly used in the art, unless otherwise specified. The methods in the following examples are conventional in the art unless otherwise specified.
For a sufficient disclosure, information on the self-isolated Bacillus bailii SL-K2 is provided below. EXAMPLE 1 isolation and characterization of Bacillus bailii SL-K2
1. Isolation and screening of strains
1.1 Experimental method:
Collecting silt at the offshore river mouth of the urban wetland park in the sea city, putting into a sterile plastic bag, feeding into a laboratory for experiment, weighing 10g of soil (uniformly mixing in advance), adding 90ml of sterile water, oscillating for 15min on a shaking table at 190r/min to prepare 10 -1 bacterial suspension, filling 9 test tubes into 9ml of sterile water, sucking 1ml of 10 -1 bacterial suspension by a microsampler, injecting into a first test tube, marking the test tube as 10 -2, fully shaking to prepare 10 -2 bacterial suspension, and serially diluting to 10 -3,10-4,10-5,10-6,10-7,10-8,10-9,10-10 bacterial suspension. Respectively sucking 100 μm from 10 -2,10-4,10-6,10-8,10-10 bacterial suspension, injecting into LB solid culture medium prepared in advance, uniformly coating with a coating rod, and culturing in a 37 deg.C incubator for 1-2d. And (3) selecting single colonies with different culture characteristics, purifying by a plate streak separation method, and carrying out antagonism experiments on the purified strains and Fusarium roseum. And screening antagonistic bacteria by adopting a flat plate counter method, and finally observing whether a bacteria inhibition zone appears between two bacterial colonies.
1.2 Results and analysis
As shown in figure 1, a strain of bacteria is separated, has good antibacterial effect on Fusarium roseum, and well prevents the expansion of Fusarium roseum when being cultivated in a counter manner, and is named as: SL-K2 strain.
2. Observation of morphological characteristics of SL-K2 strain morphological antagonistic bacteria
2.1 Experimental methods
(1) Observation of colony appearance: the antagonistic bacteria obtained by screening are streaked by a flat plate and cultured for 24 hours in a constant temperature incubator at 37 ℃, the morphological characteristics of the observed colony are referred to the handbook of the identification of common bacterial systems, and the analysis of gram staining and physiological and biochemical characteristics are referred to the experiments of microbiology.
(2) Spore staining: picking and culturing the antagonistic bacteria smear for 48 hours, dyeing the antagonistic bacteria smear with saturated malachite green water solution for 10 minutes, flushing the antagonistic bacteria smear with tap water, then dyeing the antagonistic bacteria smear with safranine staining solution for 1 minute, washing the antagonistic bacteria smear with water, and performing microscopic examination after the antagonistic bacteria smear is sucked by absorbent paper.
2.2 Results and analysis
The strain is facultative aerobic bacteria, gram positive bacteria, and spores are positioned in the middle or at the partial ends of the bacteria, so that the bacteria do not expand when the spores are generated, and the bacteria are in a rod shape. As can be seen from FIG. 1, the colony surface of the strain is opaque, dirty white or yellowish. Single cells were observed under electron microscopy to be 1.3-2.7 microns long without capsules (see FIG. 1). The spores are 0.8-1.5 microns long, oval, centered or slightly biased in the cell (FIG. 3).
In addition, the SL-K2 strain was sent to the Optimago company for sequencing, and analysis and comparison result identification of the 16SrDNA gene of the SL-K2 strain revealed that the SL-K2 strain was a novel Bacillus bailii (Bacillus velezensis).
EXAMPLE 2 preparation and identification of guanine extracts of Bacillus bailii
In this example, an experimental group and a control group were set, and the experimental group was operated according to the following steps, while the control group was prepared from the same extraction material and steps as the experimental group, except that the step of induction treatment of fusarium spores of malus spectabilis was omitted.
1. Experimental method
(1) Culture medium configuration
The formula of the liquid culture medium comprises: 5% of 10 4/ml of fusarium oxysporum liquid, 0.1% of beef extract, 0.5% of peptone, 0.5% of bean cake powder, 1.0% of corn steep liquor, 0.1% of CaCO 3, 0.03% of MgSO 4 and the balance of water.
The preparation method of the fusarium oxysporum inactivated solution for the malus spectabilis comprises the following steps: the microspores of Fusarium roseum are treated for 30min at 60 ℃ to keep the spore cell morphology intact but lose germination activity, so as to prepare the inactivated spore liquid. Spores in the inactivated liquid lose germination activity, do not generate toxin, but can induce bacillus bailii to generate antibacterial substances.
(2) Culturing and fermenting bacillus bailii
Mycelia of Bacillus bailii SL-K2 were inoculated into 50ml of the above liquid medium, subjected to shaking culture at 37℃at 150rpm/min for 48 hours to obtain a seed solution, and then inoculated into 300ml of the above liquid medium at 8% of the inoculum size, subjected to shaking culture at 37℃at 150rpm/min for 48 hours to obtain a fermentation broth.
(3) Preparation of fermentation broth dry powder
Centrifuging the fermentation liquor after pathogen spore induction culture, separating thalli from the fermentation liquor, removing thalli, ventilating and drying the supernatant of the fermentation liquor at 50 ℃ in a drying box, and grinding the dried mixture into powder to obtain dry powder of the fermentation liquor. In other embodiments, the freeze-drying process can be used to obtain the freeze-dried powder of the fermentation broth, so that the effect is equivalent, and the processing efficiency of the drying process is higher, thus being more suitable for mass production.
(4) The dry powder was subjected to ethanol precipitation with 10 volumes of ethanol, kept at 4 ℃ for 24 hours, and then filtered with filter paper to separate the filtrate from the precipitate.
(5) Dialysis treatment of primary extract
Removing ethanol in the precipitate by rotary evaporator to obtain dry powder, dissolving the dry powder in DMSO (dimethyl sulfoxide), dialyzing, and removing macromolecules above 500Da to obtain secondary extractive solution.
(6) Chromatographic purification treatment
The secondary extract was subjected to high performance liquid chromatography purification using a Hypersil GOLD C18 column (2.1X100 mm,5 μm; thermo FISHER SCIENTIFIC, waltham, USA) at a column temperature of 25deg.C in a two-dimensional nano-liquid phase system at flow rates of 1.0ml/min at 0:3,1:9, 14:90, 13:7 and 18:5. In the elution process, acetic acid (90%) is adopted as eluent A, B is a system for removing acetonitrile and methanol (8% of acetonitrile and 2% of methanol), the chromatographic retention time is 1.5-1.6min, and finally 1 refined extract of bacillus belicus is obtained by purification.
(7) Mass spectrometry analysis
Carrying out mass spectrometry on the refined extract, and carrying out full scanning on positive ions and negative ions in a nuclear mass ratio range of 50-1500m/z by electrospray mass spectrometry, wherein nitrogen is used as atomizing gas, and the flow rate is 6L/min; the temperature is 180 ℃; pressure was 1.0Bar and data acquisition and processing used LC/MS data analysis software supplied with the instrument (version 4.1). The nuclear mass ratio data corresponding to a particular elemental composition is calculated using formula prediction software provided with the instrument. It is required that the error between the measured nuclear mass ratio and the standard nuclear mass ratio of the substance is not more than 5ppm.
2. Experimental results and analysis
The result of the chromatograms of the refined extract of bacillus belicus is shown in fig. 4 and 6, and the positive ion mass spectrum and the negative ion spectrum of the refined extract are shown in fig. 7 and 5 respectively.
By analyzing the negative ion mass spectrum of FIG. 5, the maximum peak is a molecular ion peak, the M/Z value is 150.0148, and the unique molecular formula is C 5H5N5 O (negative ion hydrogenation: C 5H4N5 O is C 5H5N5 O after H is added) given by LC/MS data analysis software (version 4.1) provided by an instrument. Meanwhile, the analysis of the positive ion spectrum chart of fig. 7 shows that the unique molecular formula is also C 5H5N5 O (the positive ion is reduced in hydrogen, namely C 5H6N5 O is added with H and then is C 5H5N5 O).
Furthermore, the retention time of the material signal of the positive and negative ions is within 1.5-1.6 min. The guanine chemical structure is 2-amino-6-hydroxy purine, the signal is also analyzed by anion chromatography because of hydroxy, and the signal of positive ion mass spectrum is strong because guanine has amino as alkalescence, and the prior mass spectrum characteristic related report about guanine and the precursor peak in mass spectrum are combined: xanthine (see FIG. 3), the refined extract compound was inferred to be guanine.
Whereas no compound C 5H5N5 O was found in the control extract, this indicates: without induction treatment of pathogenic bacteria, fusarium roseum spores, bacillus belicus SL-K2 did not express the compound: guanine.
EXAMPLE 3 use of guanine extract of Bacillus bailii
1. Experimental method
Since it has been found in the past that guanine does not directly inhibit the growth of pathogenic bacteria, the applicant speculates that guanine induces plant autoimmune reactions as an elicitor, thereby inhibiting the invasion and spread of plant pathogenic bacteria. Therefore, in this example, a potting method, i.e., a potting potato, was used to determine the indirect bacteriostatic effect of guanine extract of SL-K2 strain on Fusarium roseum.
(1) Culturing of indicator bacteria:
Fusarium roseum is inoculated in PDA solid culture medium and cultured at 28 deg.c for 7 days.
Then the spores of the fungus are washed from the surface of the mycelium by sterile physiological saline to prepare spore suspension, and the concentration is adjusted to 10 6/ml by the counting of a blood cell counting plate for standby.
(2) Sample set arrangement:
The experimental and control groups were each set with at least 3 replicates according to the following procedure:
Water control group (CK): filling with equal amount of sterile distilled water.
Treatment group a: basically the same as the method of the experimental group 2, only the step of fusarium spore induction treatment is omitted and is used as a sample;
Treatment group B: the guanine refined extract prepared according to the complete experimental steps is taken as a sample;
treatment group C: and centrifuging the fermentation liquor of bacillus belicus subjected to pathogen-fusarium spore induction treatment to remove thalli, and separating the thalli by a molecular sieve to remove substances above 500D as a sample, wherein the pretreatment is the same as the pretreatment of the refined extract.
The samples of each experimental group were dissolved in sterile distilled water to prepare 10mg/ml solutions, and filtered through a 0.22 μm sterile filter.
(3) Potting experiment
Root irrigation treatment is carried out on each pot of potato seedlings by using equal amounts of sterile water (CK) and A, B, C treatment groups of sample diluents (the concentration is 10 mg/ml), 1500ml of each pot is put into light for 1-2 days, 10ml of activated fusarium oxysporum spore suspension (10 6/ml) with the same amount is inoculated, and the growth condition of plants is observed and recorded. Each set of experiments was set up with 3 replicates and the results were analyzed and plotted for statistically significant differences.
Seedling growth vigor and total weight measurements were performed for each group, and indexes such as chlorophyll content (chlorophyll a, chlorophyll b, and total chlorophyll content) of plants, soluble sugar, malondialdehyde content (markers of cell senescence degree) were measured, and the measurement method was as follows: spectrophotometric assay. Each set of experiments was repeated 3 times.
Chlorophyll, which includes chlorophyll a, is the primary pigment that absorbs solar energy for photosynthesis. The chlorophyll a content is high, the photosynthetic capacity of the leaf is strong, and the stronger the resistance to strong light. The soluble sugar can help plant cells to maintain water balance, improve cell osmotic pressure and protect cell membranes, and can accumulate when plants are in adverse conditions, and when the content of the soluble sugar is high, the plants can attract small insects to gnaw plant leaves, and simultaneously, virus diseases can be transmitted, so the content of the soluble sugar is one of important indexes for reflecting the stress resistance of the plants.
Plant organs age or suffer injury in adverse circumstances, membrane lipid peroxidation often occurs, and Malondialdehyde (MDA) is the final breakdown product of membrane lipid peroxidation. Therefore, the lower the malondialdehyde content, the better the state of the plant and the good stress resistance. Malondialdehyde as a marker of the degree of cellular senescence can reflect stress resistance of plants. Therefore, in this embodiment, the plurality of indices are measured separately.
The obtained data are subjected to difference significance analysis and drawing by using SAS data processing software.
2. Experimental results and analysis
(1) From the results of FIGS. 8 and 9, it can be seen that the control inoculated with Fusarium roseum was frequently associated with wilting. The treatment B (guanine extract) has the best action on the potato seedlings against Fusarium roseum wilt, so that the seedlings grow best, and the total weight of the seedlings is far larger than that of other experimental groups; and the treatment C (induced fermentation broth filtrate) is inferior to the treatment A (fermentation broth filtrate induced by no pathogenic bacterial spore suspension), the capability of resisting Fusarium roseum is very weak, and seedlings are weak and sallow.
Compared with the control and other 2 treatments, the guanosine refined extract (treatment B) has the best effect of promoting the growth and resisting the stress of the potatoes, and the chlorophyll a content is the highest, so that the photosynthesis is stronger, the organic matters are more synthesized in unit time, and the plant growth is faster; meanwhile, the content of the soluble sugar and malondialdehyde is the lowest, the low content of the soluble sugar can reduce the harm of small insects, and many small insects are also transmission media of plant virus diseases, so that the probability of infection of potato plants by viruses can be reduced. The lowest content of malondialdehyde indicates that the B-treated potato seedlings have the strongest stress resistance.
(2) As can be seen from the comparison of the A group and the B, C group, the induction of the fusarium spore suspension of the malus spectabilis has a decisive effect on the generation of guanine in the fermentation liquor, and the fusarium which resists the malus spectabilis and is prepared by the method has the strongest effect and shows the effect of promoting the growth of seedlings. While the A treatment without spore suspension induction showed a weaker resistance to Fusarium, it is presumed that other substances in the fermentation broth also have a certain inhibition effect on Fusarium.
It will be understood that equivalents and modifications will occur to those skilled in the art in light of the present teachings and concepts, and all such modifications and substitutions are intended to be included within the scope of the present invention as defined in the accompanying claims.
Claims (8)
1. The application of bacillus beleiensis (Bacillus velezensis) SL-K2 in the preparation of guanine is characterized in that the preservation number of bacillus beleiensis SL-K2 is CGMCC No.28155.
2. A process for the preparation of guanine, characterized by: guanine is extracted from the fermentation broth of bacillus belgium SL-K2 according to claim 1.
3. The method for preparing guanine according to claim 2, characterized by comprising the following steps:
s1, centrifuging fermentation liquor of bacillus belicus SL-K2, removing thalli, and reserving a fermentation liquor supernatant;
s2, drying and grinding the supernatant of the fermentation broth into powder to obtain dry powder of a fermentation broth mixture;
S3, performing alcohol precipitation on dry powder of the fermentation liquor mixture by 8-12 times of ethanol, keeping for 20-30 hours, filtering with filter paper, separating filtrate and precipitate, and precipitating to obtain a primary extract;
S4, removing ethanol in the precipitate obtained in the previous step, preparing dry powder, dissolving the dry powder, and performing dialysis treatment to remove macromolecules with a size of more than 500Da to obtain a secondary extract;
s5, performing HPLC (high Performance liquid chromatography) purification on the secondary extract, and separating to obtain a refined extract, wherein the refined extract is guanine.
4. The process for producing guanine according to claim 3, wherein the fermentation broth of Bacillus belicus SL-K2 in the step S1 is produced by:
Inoculating bacillus belicus SL-K2 into a liquid culture medium, and shake culturing for 40-55 h, wherein the rotation speed of a shaking table is 120-200 rpm, so as to obtain a culture solution; the liquid culture medium is added with fusarium microspore inactivating liquid of the malus spectabilis.
5. The preparation method of guanine according to claim 4, wherein the liquid culture medium comprises the following components in percentage by mass:
1-10% of fusarium oxysporum microspore inactivating liquid with the concentration of 10 3~105/ml, 0.05-0.5% of beef extract, 0.1-1% of peptone and 0.1-1% of bean cake powder; 0.5-3% corn steep liquor; 0.05-0.3% CaCO 3; 0.01-0.05% of MgSO 4 and the balance of water.
6. The preparation method of guanine according to claim 5, wherein the preparation method of the fusarium oxysporum virens microspore inactivation solution of the malus spectabilis comprises the following steps: and (3) treating the microspore suspension of Fusarium roseum at 55-65 ℃ for 20-40 min.
7. The use of guanine as defined in claim 2 for promoting plant growth.
8. The use of guanine as defined in claim 2 for increasing disease resistance of potato against fusarium wilt of begonia.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311245655.0A CN117305388B (en) | 2023-09-25 | 2023-09-25 | Application of bacillus bailii SL-K2 in preparation of guanine extract, preparation method of guanine extract and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311245655.0A CN117305388B (en) | 2023-09-25 | 2023-09-25 | Application of bacillus bailii SL-K2 in preparation of guanine extract, preparation method of guanine extract and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117305388A CN117305388A (en) | 2023-12-29 |
CN117305388B true CN117305388B (en) | 2024-04-26 |
Family
ID=89249289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311245655.0A Active CN117305388B (en) | 2023-09-25 | 2023-09-25 | Application of bacillus bailii SL-K2 in preparation of guanine extract, preparation method of guanine extract and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117305388B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108265012A (en) * | 2016-12-30 | 2018-07-10 | 北京绿色农华作物科技有限公司 | A kind of Bei Laisi Bacillus strains and its microbial inoculum and application |
CN111411134A (en) * | 2019-09-18 | 2020-07-14 | 大连民族大学 | Preparation method for producing purine by fermenting marine Bacillus sp.JIN118 |
CN112522351A (en) * | 2020-12-28 | 2021-03-19 | 广东肇庆星湖生物科技股份有限公司 | Synthetic method of guanine |
CN114921360A (en) * | 2021-10-22 | 2022-08-19 | 江西农业大学 | Bacillus belgii UB201712 and preparation method and application of fermentation broth of bacillus belgii UB201712 |
CN115927066A (en) * | 2022-09-02 | 2023-04-07 | 东北农业大学 | Bacillus belgii with antagonistic effect on fusarium oxysporum and application thereof |
-
2023
- 2023-09-25 CN CN202311245655.0A patent/CN117305388B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108265012A (en) * | 2016-12-30 | 2018-07-10 | 北京绿色农华作物科技有限公司 | A kind of Bei Laisi Bacillus strains and its microbial inoculum and application |
CN111411134A (en) * | 2019-09-18 | 2020-07-14 | 大连民族大学 | Preparation method for producing purine by fermenting marine Bacillus sp.JIN118 |
CN112522351A (en) * | 2020-12-28 | 2021-03-19 | 广东肇庆星湖生物科技股份有限公司 | Synthetic method of guanine |
CN114921360A (en) * | 2021-10-22 | 2022-08-19 | 江西农业大学 | Bacillus belgii UB201712 and preparation method and application of fermentation broth of bacillus belgii UB201712 |
CN115927066A (en) * | 2022-09-02 | 2023-04-07 | 东北农业大学 | Bacillus belgii with antagonistic effect on fusarium oxysporum and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN117305388A (en) | 2023-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103952362A (en) | Citrus endophytic actinomycetes with antibacterial activity on various plant pathogens | |
CN107974427B (en) | Marine streptomyces with bacteriostatic activity | |
CN102181390B (en) | Streptomyces parvus strain and application thereof | |
CN114164135B (en) | Preparation method and application of banana vascular wilt resistant compound | |
CN103740606A (en) | Streptomyces phytohabitans, method for producing new antibiotics Novonestmycin from Streptomyces phytohabitans, and application of Novonestmycin | |
CN101720772B (en) | Macrolide composition for preventing and controlling fungal disease of crop and preparation process thereof | |
CN108102928B (en) | One plant of gingko endogenous fungus and its application | |
CN113005048B (en) | Streptomyces nigricans CYS22, metabolite thereof and application thereof | |
CN115851553B (en) | Streptomyces virginiae capable of preventing and treating clubroot and application thereof | |
CN117305388B (en) | Application of bacillus bailii SL-K2 in preparation of guanine extract, preparation method of guanine extract and application | |
CN109077068A (en) | A kind of application of fungi rod method in prevention and control exotic invasive weed Yellow calla | |
CN107771866B (en) | Preparation method of crowndaisy chrysanthemum bacteriostatic active monomer | |
CN104893986B (en) | Dragonfly enterobacteriaceae Aspergillus terreus QT122 and its metabolite and application | |
CN112961783A (en) | Plant endophytic fungus and application thereof in preparation of spironolactone derivative | |
CN113402471B (en) | Siderophore compounds derived from plant endophytic fungi as well as preparation method and application of siderophore compounds | |
CN109161484A (en) | A kind of application of toVerticilliumdahliaActivitie Activitie S of Relative in prevention and control exotic invasive weed Italy Siberian cocklebur | |
CN110172408A (en) | The endogenetic fungus of one plant of Chinese podophyllum root and its application | |
CN112877222B (en) | Strain for antagonizing sclerotinia rot of asarum and application thereof | |
CN109180593A (en) | Phenol piperazine alkaloids secondary metabolite and its application | |
CN103641810A (en) | Polyketone compound, preparation method and application thereof | |
CN109971655B (en) | Astragalus membranaceus endophytic Chaetomium sp HQ-1 and application thereof | |
CN103387529B (en) | Tripyrrole cyclics of anti-TMV and its production and use | |
CN117511753B (en) | Marine trichoderma strain and application thereof in prevention and treatment of tobacco mosaic virus | |
CN114717119B (en) | Sarcandra glabra endophytic fungus and application thereof | |
CN116144538B (en) | Streptomyces flavochromogenes capable of preventing and treating clubroot and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |